日清(01475.HK)母企次季中國經營溢利錄18.9億日圓 按年升76%
日清食品(01475.HK)公佈,控股股東日本日清截至今年6月30日止第二季中國業務收入按年增長26.5%至154.94億日圓;經營溢利達18.91億日圓,按年升76.2%。
集團表示,內地高增值面市場持續擴張,期內積極擴展其銷售地域,並強化「合味道」品牌,銷量於2021年6月實施升級改造後持續增長,預期第二季收入按年增加是由於主要產品實施價格調整後,在中國內地及香港的銷量仍有所增加,抵銷原材料成本的急劇上漲,因此亦帶來溢利按年上升。
此外,當地貨幣兌日圓換算升值亦對收入及溢利產生正面影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.